ARTERA
Artera is a provider of precision medicine and develops artificial intelligence (AI) testing to customize treatments for cancer patients. It develops specialized tools to support personalized clinical care. Its test predicts therapeutic benefits and provides risk stratification.
ARTERA
Industry:
Artificial Intelligence (AI) Biotechnology Health Care Life Science Precision Medicine
Founded:
2021-01-01
Address:
Los Altos, California, United States
Country:
United States
Website Url:
http://www.artera.ai
Total Employee:
101+
Status:
Active
Total Funding:
110 M USD
Technology used in webpage:
Mobile Non Scaleable Content IPv6 Cloudflare Hosting JsDelivr Person Schema Apple Mobile Web App Capable Cloudflare CDN Cloudflare Apple Mobile Web App Status Bar Style Cloudflare Network Error Logging
Similar Organizations
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Coriell Life Sciences
Coriell Life Sciences delivers the power of precision medicine using pharmacogenomics and clinical decision support software.
Immunitas Therapeutics
Immunitas Therapeutics is a single cell genomics-based drug discovery company that modulates oncology targets.
Novasenta
Novasenta develops treatments to transform the lives of patients with cancer.
Pera Labs
Pera Labs develops digiceuticals and AI-powered solutions for fertility.
Proscia
Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
InterVenn
InterVenn Biosciences identifies, quantifies, and classifies Glycoproteomic and other PTM signals found in human blood and tissue.
Current Advisors List
Current Employees Featured
Founder
Investors List
Trium
Trium investment in Venture Round - Artera
Andrew Tan
Andrew Tan investment in Venture Round - Artera
AIspace Ventures
AIspace Ventures investment in Venture Round - Artera
Rajiv Khemani
Rajiv Khemani investment in Venture Round - Artera
Walden Catalyst
Walden Catalyst investment in Venture Round - Artera
Wilson Sonsini Goodrich & Rosati
Wilson Sonsini Goodrich & Rosati investment in Venture Round - Artera
EDBI
EDBI investment in Venture Round - Artera
Prosperity7 Ventures
Prosperity7 Ventures investment in Venture Round - Artera
Navin Chaddha
Navin Chaddha investment in Venture Round - Artera
Coatue
Coatue investment in Venture Round - Artera
Official Site Inspections
http://www.artera.ai Semrush global rank: 4.24 M Semrush visits lastest month: 2.35 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Artera"
ArteraAI | World Economic Forum
ArteraAI is a US-based medical artificial intelligence (AI) start-up that develops AI tests that personalize therapy for cancer patients. Artera's flagship test, the ArteraAI Prostate Cancer …See details»
Andre Esteva
Artera develops medical AI tests that personalize therapy for cancer patients. These are multi-modal computer vision tests that take digitized histopathology images and prognosticate …See details»
Artera, with Salesforce and UCSF links, OK'd for prostate cancer
16 hours ago Artera's AI prostate cancer tool wins FDA clearance. Salesforce alum's AI startup targets prostate cancer treatment. Benioff-backed Artera gets FDA nod for AI cancer …See details»
Artera Review – Cost, Use Cases & Alternatives [2025]
Jul 29, 2025 Artera is an AI-powered tool designed to assist in the diagnosis and treatment of prostate cancer. It uses multimodal AI (MMAI) to analyze several types of medical data, such as imaging scans, genetic …See details»
AI in Healthcare Communications Boosts Efficiency
Artera’s AI Agents (voice and text) are your new digital office staff—intelligent, autonomous assistants that streamline operations and support decision-making. These dynamic agents work alongside your …See details»
How ArteraAI Revolutionized Prostate Cancer …
Feb 28, 2025 How did Andre come up with the idea for ArteraAI? Andre Esteva, the mind behind ArteraAI, noticed a significant challenge in prostate cancer treatment: the difficulty in personalizing therapy for patients due to …See details»
ArteraAI: Explore Open Positions and Learn About Our Company
About ArteraAI Artera.ai is a pioneering company at the forefront of artificial intelligence (AI) and machine learning (ML) technologies. With a mission to revolutionize industries through cutting …See details»
FDA grants de novo authorization to ArteraAI Prostate
Aug 13, 2025 The FDA has granted de novo authorization to ArteraAI Prostate, an artificial intelligence (AI)-powered risk stratification tool for patients with non-metastatic prostate …See details»
Personalizing Prostate Cancer Therapy with AI
Personalized Cancer Therapy with AI. Artera's advanced AI enables personalized approaches to cancer therapy for individualized patient care.See details»
Company - Artera
Artera enhances every stage of the patient experience with AI-powered virtual agents (voice and text) designed for healthcare. Trusted by 1,000+ provider organizations engaging 100 million patients annually. Artera …See details»
Meet the Experts Driving Personalized Prostate Cancer Therapy …
Meet Artera’s team of experts Built on a diverse set of skills within the medical and AI industries, our team is connected by a shared goal of establishing a more personalized approach to …See details»
AI Agents in Healthcare: Save Revenue & Time - artera.io
Artera’s AI Agents (voice and text) leverage the leading large language, text-to-speech, speech-to-text and generative voice models to engage patients in a dynamic and completely realistic …See details»
Artera gets FDA okay for prostate cancer AI | pharmaphorum
Aug 14, 2025 Artificial intelligence specialist Artera has won FDA approval for AI-powered software that can help guide the management of patients diagnosed with localised prostate …See details»
FDA grants de novo authorisation to Artera’s prostate software
Aug 14, 2025 The US Food and Drug Administration (FDA) has granted de novo authorisation to Artera’s ArteraAI Prostate software. This marks it as an inaugural AI-powered software with …See details»
FDA approved AI device that predicts cancer prognosis - Quartz
Aug 14, 2025 FDA just signed off on AI predicting long-term cancer outcomes The ArteraAI prostate test uses artificial intelligence and biomarkers to predict if standard hormone therapy …See details»
Advanced AI Prostate Cancer Test | ArteraAI
Revolutionizing prostate cancer treatment with ArteraAI's advanced AI solution. Discover personalized precision medicine for optimal course of treatment.See details»
How AI is helping to improve patient care in the healthcare …
Sep 23, 2024 About Artera: *Artera is a SaaS digital health leader redefining patient communications. Artera is trusted by 800+ healthcare systems and federal agencies to …See details»
Artera’s AI/ML Architecture - Innovation @Artera
Aug 26, 2024 Artera’s AI/ML ArchitectureAI/ML Architecture at Artera The Artificial Intelligence and Machine Learning (AI/ML) world is iterating at an astonishing rate. New technologies and …See details»
Join Artera's Team and Help Shape the Future of AI in Healthcare
Join Artera's team and contribute to shaping the future of healthcare with leading-edge AI.See details»
Artera’s Approach to AI - Innovation @Artera
Nov 12, 2024 The Artera platform integrates across a healthcare organization’s tech stack, EHRs and third-party vendors to unify, simplify and orchestrate digital communications into the …See details»